BRIEF-Syros announces approval of Investigational Device Exemption (IDE) for blood test to identify cancer patients with proprietary biomarkers
Oct 11 Syros Pharmaceuticals Inc
* Syros announces approval of investigational device exemption (IDE) for blood test to identify cancer patients with proprietary biomarkers
* Syros Pharmaceuticals-approval of IDE allows Co to expand phase 2 clinical trial to include newly diagnosed AML patients 60 years of age or older Source text for Eikon: Further company coverage:
AT&T reaches deal to buy Time Warner for more than $80 billion -WSJ
Oct 22 AT&T Inc reached a deal to buy media company Time Warner Inc for more than $80 billion, The Wall Street Journal reported on Saturday.
Trump vows to weaken U.S. media 'power structure' if elected
GETTSYBURG, Pa. , Oct 22 U.S. Republican presidential candidate Donald Trump promised on Saturday to foil a proposed deal for AT&T Inc to buy Time Warner Inc if he wins the Nov. 8 election, arguing it was an example of a "power structure" rigged against both him and voters.